Literature DB >> 16216938

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Miia Kivipelto1, Tiia Ngandu, Laura Fratiglioni, Matti Viitanen, Ingemar Kåreholt, Bengt Winblad, Eeva-Liisa Helkala, Jaakko Tuomilehto, Hilkka Soininen, Aulikki Nissinen.   

Abstract

BACKGROUND: Vascular risk factors play a role in the development of dementia, including Alzheimer disease (AD). However, little is known about the effect of body mass index and clustering of vascular risk factors on the development of dementia.
OBJECTIVE: To investigate the relation between midlife body mass index and clustering of vascular risk factors and subsequent dementia and AD. DESIGN AND
SETTING: Participants of the Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) study were derived from random, population-based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average follow-up of 21 years, 1449 individuals (73%) aged 65 to 79 years participated in the reexamination in 1998. MAIN OUTCOME MEASURES: Dementia and AD.
RESULTS: Obesity at midlife (body mass index>30 kg/m2) was associated with the risk of dementia and AD even after adjusting for sociodemographic variables (odds ratio [OR], 2.4 [95% confidence interval (CI), 1.2-5.1]). The association was somewhat modified by further adjusting for midlife blood pressure, total cholesterol level, and smoking (OR, 2.1 [95% CI, 1.0-4.6]) and also for apolipoprotein E genotype and history of vascular disorders (OR, 1.9 [95% CI, 0.8-4.6]). Midlife obesity, high total cholesterol level, and high systolic blood pressure were all significant risk factors for dementia with ORs of around 2 for each factor, and they increased the risk additively (OR, 6.2 for the combination).
CONCLUSIONS: Obesity at midlife is associated with an increased risk of dementia and AD later in life. Clustering of vascular risk factors increases the risk in an additive manner. The role of weight reduction for the prevention of dementia needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216938     DOI: 10.1001/archneur.62.10.1556

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  419 in total

Review 1.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study.

Authors:  Adesola Ogunniyi; Su Gao; Frederick W Unverzagt; Olusegun Baiyewu; Oyewusi Gureje; James Tat Nguyen; Valerie Smith-Gamble; Jill R Murrell; Ann M Hake; Kathleen S Hall; Hugh C Hendrie
Journal:  Int Psychogeriatr       Date:  2010-08-25       Impact factor: 3.878

Review 4.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

Review 5.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

6.  Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.

Authors:  Kamile Silay; Ahmet Yalcin; Sema Akinci; Fatma Gul Gursoy; Didem Sener Dede
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

7.  Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women.

Authors:  Chitra Lal; Michelle M DiBartolo; Suchit Kumbhare; Charlie Strange; Jane E Joseph
Journal:  Sleep Breath       Date:  2015-09-18       Impact factor: 2.816

Review 8.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

9.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

10.  Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.